Natalie Houwing is a Senior Research Consultant, Strategic Market Access, in the Rotterdam office. Natalie’s expertise includes the preparation of global value dossiers, literature reviews, HEOR evidence generation plans, reimbursement dossiers and cost-effectiveness analyses.
Natalie has > 20 years of experience within pharmaceutical industry and as a healthcare consultant. Before joining Pharmerit in 2007, Natalie worked in Research & Development of Organon for 12 years. During this period Natalie participated in multidisciplinary R&D teams as an expert on Clinical Pharmacology/PK-PD. She was involved in the design of clinical trials and clinical development programs in anesthesia, depression, schizophrenia, testosterone replacement therapy and women’s health. She represented her discipline at meetings with regulatory authorities (FDA, EMA). Within Pharmerit, Natalie has worked on a variety of projects in a wide range of therapeutic areas including mental disorders, chronic pain, hematology, diabetes and oncology.
Natalie holds a M.Sc. degree in Biopharmaceutical Sciences from the University of Leiden, the Netherlands.